
|Articles|May 1, 2010
Evaluation of the change in tear osmolarity after using different eye drops
Left untreated, dry eye can cause many problems in the post operative period. As many as 33 million adults may be undiagnosed
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: EU-ROP Registry bridges borders for real-world insight
2
FLORetina 2025: New horizons in research and risk management for ROP
3
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
4
FLORetina 2025: Navigating antithrombotic therapy in wet AMD
5













































